Tuesday, May 8, 2012

Sutro Biopharma lines up funding, targets cancer

Sutro Biopharma Inc. is ready for war. The South San Francisco biotech company closed the second tranche of a $36 million Series C venture round, it said Tuesday, and is readying the infrastructure it needs to produce highly targeted, cancer-fighting antibody-drug conjugates.

No comments:

Post a Comment